Volume | 124 799 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 1,1828 | Bas Haut |
|||||
Minimum Bas | 1,06 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Seelos Therapeutics Inc | SEEL | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,12 | 1,06 | 1,1828 | 1,07 | 1,125 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
1 220 | 124 799 | US$ 1,10 | US$ 137 665 | - | 0,24 - 49,80 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
01:03:32 | 10 | US$ 1,12 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
14,64M | 13,68M | - | 2,2M | -37,88M | -2,77 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Seelos Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
05/6/2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
31/5/2024 | 22:30 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
21/5/2024 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
20/5/2024 | 22:16 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
16/5/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
14/5/2024 | 17:45 | Edgar (US Regulatory) | Form 8-K - Current report |
14/5/2024 | 14:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
06/3/2024 | 23:32 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
06/3/2024 | 22:50 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
01/3/2024 | 23:39 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
06/2/2024 | 23:26 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
02/2/2024 | 12:04 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
Forum Action Seelos Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Seelos Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 1,25 | 1,25 | 1,06 | 1,14 | 73 426 | -0,18 | -14,40% |
1 mois | 0,29 | 2,43 | 0,24 | 0,6390686 | 317 181 | 0,78 | 268,97% |
3 mois | 1,09 | 2,43 | 0,24 | 0,520935 | 432 498 | -0,02 | -1,83% |
6 mois | 1,64 | 2,43 | 0,24 | 0,9256124 | 428 130 | -0,57 | -34,76% |
1 an | 29,40 | 49,80 | 0,24 | 9,04 | 2 039 246 | -28,33 | -96,36% |
3 ans | 101,10 | 103,80 | 0,24 | 35,23 | 1 800 128 | -100,03 | -98,94% |
5 ans | 76,50 | 198,00 | 0,24 | 64,80 | 2 045 338 | -75,43 | -98,60% |